Alterity Therapeutics Ltd - Asset Resilience Ratio

Latest as of December 2025: 86.44%

Alterity Therapeutics Ltd (ATH) has an Asset Resilience Ratio of 86.44% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

AU$49.20 Million

≈ $34.81 Million USD Cash + Short-term Investments

Total Assets

AU$56.92 Million

≈ $40.27 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2025)

This chart shows how Alterity Therapeutics Ltd's Asset Resilience Ratio has changed over time. Check Alterity Therapeutics Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Alterity Therapeutics Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Alterity Therapeutics Ltd market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$49.20 Million	86.44%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$49.20 Million	86.44%

Asset Resilience Insights

Very High Liquidity: Alterity Therapeutics Ltd maintains exceptional liquid asset reserves at 86.44% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Alterity Therapeutics Ltd Industry Peers by Asset Resilience Ratio

Compare Alterity Therapeutics Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	0.05%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Syndax Pharmaceuticals Inc NASDAQ:SNDX	Biotechnology	46.79%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	63.47%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for Alterity Therapeutics Ltd (2006–2025)

The table below shows the annual Asset Resilience Ratio data for Alterity Therapeutics Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	16.30%	AU$7.50 Million ≈ $5.31 Million	AU$46.03 Million ≈ $32.57 Million	--
2024-06-30	0.00%	AU$0.00 ≈ $0.00	AU$19.22 Million ≈ $13.60 Million	--
2022-06-30	84.15%	AU$34.81 Million ≈ $24.63 Million	AU$41.36 Million ≈ $29.27 Million	+0.44pp
2021-06-30	83.71%	AU$28.12 Million ≈ $19.89 Million	AU$33.59 Million ≈ $23.76 Million	+82.26pp
2020-06-30	1.45%	AU$192.71K ≈ $136.35K	AU$13.30 Million ≈ $9.41 Million	-70.88pp
2019-06-30	72.33%	AU$14.40 Million ≈ $10.19 Million	AU$19.91 Million ≈ $14.09 Million	-9.09pp
2018-06-30	81.41%	AU$15.25 Million ≈ $10.79 Million	AU$18.73 Million ≈ $13.25 Million	-5.33pp
2017-06-30	86.74%	AU$21.93 Million ≈ $15.52 Million	AU$25.28 Million ≈ $17.89 Million	--
2016-06-30	0.00%	AU$0.00 ≈ $0.00	AU$33.73 Million ≈ $23.86 Million	--
2015-06-30	0.36%	AU$152.60K ≈ $107.98K	AU$41.83 Million ≈ $29.60 Million	-0.23pp
2007-06-30	0.59%	AU$45.63K ≈ $32.28K	AU$7.72 Million ≈ $5.46 Million	+0.18pp
2006-06-30	0.41%	AU$42.40K ≈ $30.00K	AU$10.43 Million ≈ $7.38 Million	--

pp = percentage points

About Alterity Therapeutics Ltd

AU:ATH Australia Biotechnology

Market Cap

$4.54 Billion

AU$6.42 Billion AUD

Market Cap Rank

#18829 Global

#594 in Australia

Share Price

AU$0.59

Change (1 day)

+8.26%

52-Week Range

AU$0.01 - AU$0.71

All Time High

AU$0.71